Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care
April 17, 2024 09:23 ET
|
Progyny
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and Fertility Matters Canada, a national...
Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast
April 04, 2024 08:59 ET
|
Progyny
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and RESOLVE: The National Infertility...
Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
March 18, 2024 12:00 ET
|
Progyny
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski,...
Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference
March 11, 2024 12:00 ET
|
Progyny
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski,...
Progyny, Inc. Announces Share Repurchase Program
February 29, 2024 07:30 ET
|
Progyny
NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, announced today that its Board of...
Progyny, Inc. Announces Fourth Quarter 2023 Results
February 27, 2024 16:01 ET
|
Progyny
Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% GrowthAchieves 49% Growth in Adjusted EBITDA to Record $187.1 MillionIssues Financial Guidance for 2024, Crossing the $1.3 Billion...
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2023 Results Report
February 13, 2024 16:30 ET
|
Progyny
NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the...
Progyny Expands its Leadership Team
January 11, 2024 09:01 ET
|
Progyny
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced two newly created roles with...
Progyny, Inc. to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 08, 2024 10:30 ET
|
Progyny
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s...
Progyny, Inc. to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 10, 2023 12:00 ET
|
Progyny
NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that...